baloxavir marboxil

Details

Generic Name:
baloxavir marboxil
Therapeutic Area:
Influenza
Manufacturer:
Hoffmann-La Roche Limited
Brand Name:
Xofluza
Project Line:
Reimbursement Review
Submission Type:
Non Submission
Indications:
Treatment of uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are otherwise healthy or at high risk of developing influenza complications.
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer